NEW YORK (GenomeWeb News) –A lawsuit filed by New England Biolabs against Enzymatics has been "significantly narrowed," Enzymatics announced this week.

New England Biolabs has withdrawn its claims that Enzymatics infringed US Patent No. 5,670,637 and "conceded that US Patent No. 5,874,557 has expired, withdrawing its request for injunctive relief," Enzymatics said.